US Customs Formal Entry in 2026: A 2026 Operating Manual for Fertility Clinics & Cryo Couriers

For embryo, egg and sperm imports into the United States, 2026 is a regulatory inflection point. U.S. Customs and Border Protection (CBP) has reaffirmed its $2,500 formal-entry threshold, FDA Prior Notice rules continue to apply to almost every shipment of human cells and tissues, and CBP's ACE platform is no longer optional. If your clinic, embryologist or in-house courier is still treating "informal entry" as the default for IVF specimens, you are leaving the door open to seizure, delay, and—most importantly—loss of viable samples.

This guide breaks down what changed in 2026, what stayed the same, and exactly how GuardianCryo's hand-carry IVF transport service structures every formal entry to keep your samples moving at -196°C.

1. What is "Formal Entry" — and why it matters for IVF samples

Formal entry is CBP's structured customs process required for shipments above the threshold value, all commercial imports of FDA-regulated articles, and any cargo flagged for documentation review. For 2026, the headline threshold remains $2,500, but practical application for fertility logistics is dictated by the FDA's HCT/P (21 CFR Part 1271) framework — which treats embryos, oocytes and sperm as Human Cells, Tissues, and Cellular and Tissue-Based Products.

• Embryos and gametes are virtually always FDA-regulated → formal entry pathway
• Even "personal" intended-parent shipments are reviewed under HCT/P scrutiny
• Donor materials require donor-eligibility records at the port of entry

2. The 5-step formal entry workflow GuardianCryo runs for every USA-bound shipment

1. Pre-arrival manifest filed via ACE 24h before wheels-up.
2. FDA Prior Notice submitted through the FDA Industry Systems portal.
3. Entry Type 01 (Consumption) or 11 (Informal-but-Regulated) determined per shipment value and material classification.
4. Customs broker engagement — we use brokers licensed at IAH, JFK, LAX and ATL with HCT/P experience.
5. Hand-carry release on arrival: courier escorts the dewar through customs primary inspection, never letting the dry shipper out of sight.

3. What changed in 2026

Three operational shifts you cannot ignore:

• ACE-only filings — paper SF-7501 entries are no longer accepted.
• Stricter HCT/P documentation — donor eligibility files are now requested at primary inspection in roughly 1 of 3 international IVF imports we handle.
• Higher broker fees reflecting CBP's enhanced validation of biological imports.

4. Documentation checklist for embryo, egg and sperm imports

• Commercial invoice or non-commercial valuation letter
• FDA HCT/P determination (sexually intimate vs. donor)
• Donor-eligibility file (if applicable)
• Patient consent + chain-of-custody manifest
• Dewar serial number + last-fill record
• IATA UN3373 packing certification
• Carrier & flight manifest

5. Common mistakes that cause CBP holds in 2026

From our 2024–2026 caseload of inbound USA shipments, the four most common reasons for delay are:

1. Misclassification as "personal effects" — almost always rejected for embryos.
2. Missing FDA Prior Notice (auto-generates a 24-hour hold).
3. Donor eligibility file not on hand at arrival.
4. Liquid-state nitrogen shippers — CBP/TSA will refuse entry for true liquid cryogen.

How GuardianCryo handles the formal entry, end to end

Every inbound USA shipment we operate is filed by a licensed customs broker we maintain at the courier's port of entry. Our diaspora corridor (USA ↔ Nigeria) is filed at IAH; our European corridor at JFK; our domestic transfers stay under FDA jurisdiction without a CBP touchpoint.

Want to discuss a specific inbound corridor? Request a quote and we'll route the case to our customs lead.